SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired AlloVir, Inc. (NASDAQ: ALVR ...
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired AlloVir, Inc. (NASDAQ: ALVR ...
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has AlloVir, Inc. (ALVR) been one of those stocks this year? A ...
Shares of AlloVir (NASDAQ:ALVR) plunged 65% in morning trading Friday after the company said it was discontinuing three Phase 3 studies over efficacy concerns and will explore strategic alternatives ...
EnLink Midstream, LLC (NYSE: ENLC), relating to the proposed merger with ONEOK. Under the terms of the agreement, each outstanding EnLink common unit will be converted into 0.1412 shares of ONEOK ...
AlloVir will discontinue its three global Phase 3 posoleucel studies as those are unlikely to meet primary endpoint. No safety concerns were observed or raised by any of the independent Data Safety ...
NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback